<DOC>
	<DOCNO>NCT02528461</DOCNO>
	<brief_summary>The purpose study investigate liver affected regard inflammation fibrosis Sofosbuvir base treatment regimes chronic hepatitis C. In order examine liver heals , want use blood sample check occurrence special liver inflammation cell ( CD163 CD206 ) . To assess extent fibrosis disappear treatment , want examine liver FibroScan ( type ultrasound examination ) also preferably extraction small tissue sample . We want examine liver function inflammation scar tissue decrease , especially concern liver 's ability produce protein . Furthermore , want examine gastroscopy , circulation blood liver improve successful treatment expect result potential varicose vein esophagus vanish .</brief_summary>
	<brief_title>Macrophage Activation Markers During Sofosbuvir-based Treatment Regimes Chronic Hepatitis C</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<criteria>Hepatitis C cirrhosis HIV Hepatitis B Virus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Sofosbuvir</keyword>
	<keyword>Direct act anti-viral treatment</keyword>
	<keyword>liver cirrhosis</keyword>
</DOC>